United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-617_068d23f0-3994-f3d5-e063-6394a90ae9a4
- Product NDC
- 76420-617
- Form
- CAPSULE
- Composition / generic term
- GABAPENTIN
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200907
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (76420-617-10) · 76420-617-10
- 120 CAPSULE in 1 BOTTLE (76420-617-12) · 76420-617-12
- 240 CAPSULE in 1 BOTTLE (76420-617-24) · 76420-617-24
- 30 CAPSULE in 1 BOTTLE (76420-617-30) · 76420-617-30
- 60 CAPSULE in 1 BOTTLE (76420-617-60) · 76420-617-60
- 90 CAPSULE in 1 BOTTLE (76420-617-90) · 76420-617-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →